Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Hyper-O-GlcNAcylation activates nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB) signaling through interplay with phosphorylation and acetylation.

Ma Z, Chalkley RJ, Vosseller K.

J Biol Chem. 2017 Jun 2;292(22):9150-9163. doi: 10.1074/jbc.M116.766568. Epub 2017 Apr 17.

2.

Cancer metabolism and elevated O-GlcNAc in oncogenic signaling.

Ma Z, Vosseller K.

J Biol Chem. 2014 Dec 12;289(50):34457-65. doi: 10.1074/jbc.R114.577718. Epub 2014 Oct 21. Review.

3.

O-linked β-N-acetylglucosamine (O-GlcNAc) site thr-87 regulates synapsin I localization to synapses and size of the reserve pool of synaptic vesicles.

Skorobogatko Y, Landicho A, Chalkley RJ, Kossenkov AV, Gallo G, Vosseller K.

J Biol Chem. 2014 Feb 7;289(6):3602-12. doi: 10.1074/jbc.M113.512814. Epub 2013 Nov 26.

4.

O-GlcNAc in cancer biology.

Ma Z, Vosseller K.

Amino Acids. 2013 Oct;45(4):719-33. doi: 10.1007/s00726-013-1543-8. Epub 2013 Jul 9. Review.

PMID:
23836420
5.

Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.

Ma Z, Vocadlo DJ, Vosseller K.

J Biol Chem. 2013 May 24;288(21):15121-30. doi: 10.1074/jbc.M113.470047. Epub 2013 Apr 16.

6.

Tandem lectin weak affinity chromatography for glycoprotein enrichment.

Ma ZY, Skorobogatko Y, Vosseller K.

Methods Mol Biol. 2013;951:21-31. doi: 10.1007/978-1-62703-146-2_2.

PMID:
23296521
7.

Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation.

Yuzwa SA, Shan X, Macauley MS, Clark T, Skorobogatko Y, Vosseller K, Vocadlo DJ.

Nat Chem Biol. 2012 Feb 26;8(4):393-9. doi: 10.1038/nchembio.797.

PMID:
22366723
8.

Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis.

Lynch TP, Ferrer CM, Jackson SR, Shahriari KS, Vosseller K, Reginato MJ.

J Biol Chem. 2012 Mar 30;287(14):11070-81. doi: 10.1074/jbc.M111.302547. Epub 2012 Jan 24.

9.

Carbon monoxide-releasing molecule-2 decreases fibrinolysis in vitro and in vivo in the rabbit.

Nielsen VG, Arkebauer MR, Wasko KA, Malayaman SN, Vosseller K.

Blood Coagul Fibrinolysis. 2012 Jan;23(1):104-7. doi: 10.1097/MBC.0b013e32834ea012.

PMID:
22143252
10.

Detection and analysis of proteins modified by O-linked N-acetylglucosamine.

Zachara NE, Vosseller K, Hart GW.

Curr Protoc Protein Sci. 2011 Nov;Chapter 12:Unit12.8. doi: 10.1002/0471140864.ps1208s66.

11.

Carbon monoxide and nitric oxide modulate α₂-antiplasmin and plasmin activity: role of heme.

Arkebauer MR, Kanaparthy SS, Malayaman SN, Vosseller K, Nielsen VG.

Blood Coagul Fibrinolysis. 2011 Dec;22(8):712-9. doi: 10.1097/MBC.0b013e32834c73f9.

PMID:
22024794
12.

Carbon monoxide-releasing molecule-2 enhances coagulation in rabbit plasma and decreases bleeding time in clopidogrel/aspirin-treated rabbits.

Nielsen VG, Chawla N, Mangla D, Gomes SB, Arkebauer MR, Wasko KA, Sadacharam K, Vosseller K.

Blood Coagul Fibrinolysis. 2011 Dec;22(8):756-9. doi: 10.1097/MBC.0b013e32834c7412.

PMID:
22008906
13.

Redox-based thrombelastographic method to detect carboxyhemefibrinogen-mediated hypercoagulability.

Nielsen VG, Arkebauer MR, Vosseller K.

Blood Coagul Fibrinolysis. 2011 Dec;22(8):657-61. doi: 10.1097/MBC.0b013e32834aa7b0.

PMID:
21822126
14.

Detection and analysis of proteins modified by O-linked N-acetylglucosamine.

Zachara NE, Vosseller K, Hart GW.

Curr Protoc Mol Biol. 2011 Jul;Chapter 17:Unit 17.6. doi: 10.1002/0471142727.mb1706s95.

15.

Fibrinogen is a heme-associated, carbon monoxide sensing molecule: a preliminary report.

Nielsen VG, Cohen JB, Malayaman SN, Nowak M, Vosseller K.

Blood Coagul Fibrinolysis. 2011 Jul;22(5):443-7. doi: 10.1097/MBC.0b013e328345c069.

PMID:
21451399
16.
17.

Mapping O-GlcNAc modification sites on tau and generation of a site-specific O-GlcNAc tau antibody.

Yuzwa SA, Yadav AK, Skorobogatko Y, Clark T, Vosseller K, Vocadlo DJ.

Amino Acids. 2011 Mar;40(3):857-68. doi: 10.1007/s00726-010-0705-1. Epub 2010 Aug 13.

PMID:
20706749
18.

Human Alzheimer's disease synaptic O-GlcNAc site mapping and iTRAQ expression proteomics with ion trap mass spectrometry.

Skorobogatko YV, Deuso J, Adolf-Bryfogle J, Nowak MG, Gong Y, Lippa CF, Vosseller K.

Amino Acids. 2011 Mar;40(3):765-79. doi: 10.1007/s00726-010-0645-9. Epub 2010 Jun 19. Erratum in: Amino Acids. 2012 Jun;42(6):2529. Adolf-Bergfoyle, Jared [corrected to Adolf-Bryfogle, Jared].

PMID:
20563614
19.

Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1.

Caldwell SA, Jackson SR, Shahriari KS, Lynch TP, Sethi G, Walker S, Vosseller K, Reginato MJ.

Oncogene. 2010 May 13;29(19):2831-42. doi: 10.1038/onc.2010.41. Epub 2010 Mar 1.

PMID:
20190804
20.

O-GLcNAc post-translational modifications regulate the entry of neurons into an axon branching program.

Francisco H, Kollins K, Varghis N, Vocadlo D, Vosseller K, Gallo G.

Dev Neurobiol. 2009 Feb 1-15;69(2-3):162-73. doi: 10.1002/dneu.20695.

21.

In vivo modulation of O-GlcNAc levels regulates hippocampal synaptic plasticity through interplay with phosphorylation.

Tallent MK, Varghis N, Skorobogatko Y, Hernandez-Cuebas L, Whelan K, Vocadlo DJ, Vosseller K.

J Biol Chem. 2009 Jan 2;284(1):174-81. doi: 10.1074/jbc.M807431200. Epub 2008 Nov 11.

22.

Recognition of a ubiquitous self antigen by prostate cancer-infiltrating CD8+ T lymphocytes.

Savage PA, Vosseller K, Kang C, Larimore K, Riedel E, Wojnoonski K, Jungbluth AA, Allison JP.

Science. 2008 Jan 11;319(5860):215-20. doi: 10.1126/science.1148886.

23.

Proteomics of Alzheimer's disease: Unveiling protein dysregulation in complex neuronal systems.

Vosseller K.

Proteomics Clin Appl. 2007 Nov;1(11):1351-61. doi: 10.1002/prca.200700323. Epub 2007 Oct 16.

PMID:
21136635
24.

Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats.

Akimoto Y, Hart GW, Wells L, Vosseller K, Yamamoto K, Munetomo E, Ohara-Imaizumi M, Nishiwaki C, Nagamatsu S, Hirano H, Kawakami H.

Glycobiology. 2007 Feb;17(2):127-40. Epub 2006 Nov 9.

PMID:
17095531
25.

O-linked N-acetylglucosamine proteomics of postsynaptic density preparations using lectin weak affinity chromatography and mass spectrometry.

Vosseller K, Trinidad JC, Chalkley RJ, Specht CG, Thalhammer A, Lynn AJ, Snedecor JO, Guan S, Medzihradszky KF, Maltby DA, Schoepfer R, Burlingame AL.

Mol Cell Proteomics. 2006 May;5(5):923-34. Epub 2006 Feb 1.

26.

Perturbations in O-linked beta-N-acetylglucosamine protein modification cause severe defects in mitotic progression and cytokinesis.

Slawson C, Zachara NE, Vosseller K, Cheung WD, Lane MD, Hart GW.

J Biol Chem. 2005 Sep 23;280(38):32944-56. Epub 2005 Jul 18.

27.

Quantitative analysis of both protein expression and serine / threonine post-translational modifications through stable isotope labeling with dithiothreitol.

Vosseller K, Hansen KC, Chalkley RJ, Trinidad JC, Wells L, Hart GW, Burlingame AL.

Proteomics. 2005 Feb;5(2):388-98.

PMID:
15648052
28.

A role for N-acetylglucosamine as a nutrient sensor and mediator of insulin resistance.

Wells L, Vosseller K, Hart GW.

Cell Mol Life Sci. 2003 Feb;60(2):222-8. Review.

PMID:
12678487
29.

Diverse regulation of protein function by O-GlcNAc: a nuclear and cytoplasmic carbohydrate post-translational modification.

Vosseller K, Sakabe K, Wells L, Hart GW.

Curr Opin Chem Biol. 2002 Dec;6(6):851-7. Review.

PMID:
12470741
30.

Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications.

Wells L, Vosseller K, Cole RN, Cronshaw JM, Matunis MJ, Hart GW.

Mol Cell Proteomics. 2002 Oct;1(10):791-804.

31.
32.

Dynamic O-glycosylation of nuclear and cytosolic proteins: further characterization of the nucleocytoplasmic beta-N-acetylglucosaminidase, O-GlcNAcase.

Wells L, Gao Y, Mahoney JA, Vosseller K, Chen C, Rosen A, Hart GW.

J Biol Chem. 2002 Jan 18;277(3):1755-61.

33.

Nucleocytoplasmic O-glycosylation: O-GlcNAc and functional proteomics.

Vosseller K, Wells L, Hart GW.

Biochimie. 2001 Jul;83(7):575-81. Review.

PMID:
11522385
34.

Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine.

Comer FI, Vosseller K, Wells L, Accavitti MA, Hart GW.

Anal Biochem. 2001 Jun 15;293(2):169-77.

PMID:
11399029
35.

Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc.

Wells L, Vosseller K, Hart GW.

Science. 2001 Mar 23;291(5512):2376-8. Review.

PMID:
11269319
38.

Arachidonic acid metabolism and cell proliferation in rat mammary carcinoma cells treated with indomethacin.

Tripathi SC, Vosseller KA, McCormick DL.

Biochim Biophys Acta. 1996 May 24;1316(1):5-7.

39.

Supplemental Content

Loading ...
Support Center